Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Unresectable Hepatocellular Carcinoma With Therasphere. A Human Device Evaluation Protocol.

NCT00152087 is registered in ClinicalTrials.gov with St. Joseph's Hospital, Florida as lead sponsor.

NCT NCT00152087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00152087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Unresectable Hepatocellular Carcinoma With Therasphere. A Human Device Evaluation Protocol.
Lead sponsor
St. Joseph's Hospital, Florida
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2002
Completion date
June 30, 2005
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer